Orthofix Medical (OFIX) Cash from Operations Growth (1y) (2011 - 2026)
Orthofix Medical (OFIX) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 21.54% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 13.50% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 14.62% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 124.64% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -11.16% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 78.72% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -0.23% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -12.60% |
| 10 | Orthofix Medical | 412.74 Mn | 308.34 Mn | 149.71 Mn | -153.48% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -153.48% |
| Mar 31, 2026 | 4.25% |
| Dec 31, 2025 | 16.72% |
| Sep 30, 2025 | 6.26% |
| Jun 30, 2025 | 29.55% |
| Mar 31, 2025 | 1.10% |
| Dec 31, 2024 | 454.50% |
| Sep 30, 2024 | 2,346.75% |
| Jun 30, 2024 | 262.87% |
| Mar 31, 2024 | 45.34% |
| Dec 31, 2023 | -385.09% |
| Sep 30, 2023 | 137.74% |
| Jun 30, 2023 | -12.27% |
| Mar 31, 2023 | -341.30% |
| Dec 31, 2022 | -80.07% |
| Sep 30, 2022 | -119.65% |
| Jun 30, 2022 | -125.68% |
| Mar 31, 2022 | -415.81% |
| Dec 31, 2021 | -47.16% |
| Sep 30, 2021 | -70.61% |